{
  "symbol": "CAPR",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": [
      "Biotechnology industry involvement",
      "Clinical-stage development focus",
      "Small-cap market capitalization",
      "Potential COVID-19 treatment development"
    ],
    "riskScore": 8,
    "reason": "Capricor Therapeutics operates in the biotech sector, which is prone to speculation, and has a small market cap, making it susceptible to retail-driven volatility."
  }
}